Roth J V
Department of Anesthesiology, Albert Einstein Medical Center, Philadelphia, PA 19141.
J Cardiothorac Vasc Anesth. 1992 Dec;6(6):663-7. doi: 10.1016/1053-0770(92)90047-b.
This study investigated the feasibility of transmyocardially pacing the heart using one temporary epicardial pacing lead and one endocardial lead of a pacing pulmonary artery catheter. Twenty patients undergoing cardiopulmonary bypass with cardioplegic arrest were studied 10 to 45 minutes and 18 to 30 hours after discontinuation of cardiopulmonary bypass. The Swan-Ganz Flow-Directed Pacing TD Catheter (Baxter Healthcare Corporation) was inserted in one group of 10 patients, and the Swan-Ganz Thermodilution A-V Paceport Catheter (Baxter Healthcare Corporation, Irvine, CA) was used in another group of 10 patients. Using the Pacing TD Catheter, transmyocardial atrial (TMA) pacing was successful in 14 of 16 attempts (87.5%), and transmyocardial ventricular (TMV) pacing was successful in 15 of 16 attempts (93.8%). With the AV Paceport Catheter, TMA pacing was successful in 16 of 18 attempts (88.9%), and TMV pacing was successful in 17 of 19 attempts (89.5%). Transmyocardial atrial-ventricular sequential pacing was achieved in all cases when both TMA and TMV pacing were independently successful. There were no significant differences between catheters in the success rates of either TMA or TMV. It is concluded that transmyocardial pacing is feasible using one temporary epicardial pacing lead and one endocardial lead of a pacing pulmonary artery catheter.
本研究探讨了使用一根临时心外膜起搏导线和一根起搏肺动脉导管的心内膜导线经心肌起搏心脏的可行性。对20例接受心脏停搏体外循环的患者在体外循环停止后10至45分钟以及18至30小时进行了研究。一组10例患者插入了Swan-Ganz血流导向起搏TD导管(百特医疗保健公司),另一组10例患者使用了Swan-Ganz热稀释房室起搏端口导管(百特医疗保健公司,加利福尼亚州欧文市)。使用起搏TD导管时,16次经心肌心房(TMA)起搏尝试中有14次成功(87.5%),16次经心肌心室(TMV)起搏尝试中有15次成功(93.8%)。使用房室起搏端口导管时,18次TMA起搏尝试中有16次成功(88.9%),19次TMV起搏尝试中有17次成功(89.5%)。当TMA和TMV起搏均独立成功时,所有病例均实现了经心肌房室顺序起搏。两种导管在TMA或TMV成功率方面无显著差异。得出结论,使用一根临时心外膜起搏导线和一根起搏肺动脉导管的心内膜导线经心肌起搏是可行的。